Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
the following things we are working on this may be the perfect opportunity: 1. Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection
-
approaches and biochemical assays to target key proteins. This funded position is for a postdoctoral trainee interested in aiding the development of novel therapeutics for treating cancer or metabolic disease
-
We are looking for a motivated and talented postdoctoral-level researcher with experience in executable modelling to join a cutting-edge project developing Digital Twins for rare diseases. This is a
-
populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated
-
opportunities in many Pediatric sub-specialties, not exclusive to Hematology and Oncology. Key Responsibilities Research Design & Execution: Develop and lead clinical informatics research projects focused
-
projects on metabolic diseases * Develop and apply machine learning models for biomarker discovery, patient stratification, and prediction of disease trajectories * Collaborate with clinicians
-
development and implications in neurodevelopmental disorders. Using Drosophila , mouse models, and human brain organoids, our work is at the forefront of neuroscience research, with recent publications in PNAS
-
environment (English as working language) Workshops and training for career development Requirements All research fields supported at ISTA will be eligible (see https://ista.ac.at/en/research ). At the date
-
., somatic) somatic mutations in the human brain. The lab is interested in studying somatic variation as it pertains to typical brain development as well as in neurological diseases like epilepsy. To that end
-
lead the in vivo functional analysis of this gene using conditional KO mouse models, with a focus on brain development, neuronal differentiation, and seizure susceptibility. All models are already